ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Whooping Cough Preventable Vaccine Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-7J17245
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Whooping Cough Preventable Vaccine Market Research Report 2024
BUY CHAPTERS

Global Whooping Cough Preventable Vaccine Market Research Report 2024

Code: QYRE-Auto-7J17245
Report
April 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology

Whooping Cough Preventable Vaccine Market

Whooping cough preventable vaccine is a vaccine that protects against whooping cough (pertussis). There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The global Whooping Cough Preventable Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Whooping Cough Preventable Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Whooping Cough Preventable Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Whooping Cough Preventable Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Whooping Cough Preventable Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whooping Cough Preventable Vaccine.
The Whooping Cough Preventable Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Whooping Cough Preventable Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Whooping Cough Preventable Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Whooping Cough Preventable Vaccine Market Report

Report Metric Details
Report Name Whooping Cough Preventable Vaccine Market
Segment by Type
  • Acellular Vaccines
  • Whole-Cell Vaccines
Segment by Application
  • 12 Months Below
  • 12 Months Above
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Whooping Cough Preventable Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Whooping Cough Preventable Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Whooping Cough Preventable Vaccine Market report?

Ans: The main players in the Whooping Cough Preventable Vaccine Market are Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology

What are the Application segmentation covered in the Whooping Cough Preventable Vaccine Market report?

Ans: The Applications covered in the Whooping Cough Preventable Vaccine Market report are 12 Months Below, 12 Months Above

What are the Type segmentation covered in the Whooping Cough Preventable Vaccine Market report?

Ans: The Types covered in the Whooping Cough Preventable Vaccine Market report are Acellular Vaccines, Whole-Cell Vaccines

1 Whooping Cough Preventable Vaccine Market Overview
1.1 Product Definition
1.2 Whooping Cough Preventable Vaccine by Type
1.2.1 Global Whooping Cough Preventable Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Acellular Vaccines
1.2.3 Whole-Cell Vaccines
1.3 Whooping Cough Preventable Vaccine by Application
1.3.1 Global Whooping Cough Preventable Vaccine Market Value by Application (2024-2030)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global Whooping Cough Preventable Vaccine Market Size Estimates and Forecasts
1.4.1 Global Whooping Cough Preventable Vaccine Revenue 2019-2030
1.4.2 Global Whooping Cough Preventable Vaccine Sales 2019-2030
1.4.3 Global Whooping Cough Preventable Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Whooping Cough Preventable Vaccine Market Competition by Manufacturers
2.1 Global Whooping Cough Preventable Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Whooping Cough Preventable Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Whooping Cough Preventable Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Whooping Cough Preventable Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Whooping Cough Preventable Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Whooping Cough Preventable Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Whooping Cough Preventable Vaccine, Date of Enter into This Industry
2.8 Global Whooping Cough Preventable Vaccine Market Competitive Situation and Trends
2.8.1 Global Whooping Cough Preventable Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Whooping Cough Preventable Vaccine Players Market Share by Revenue
2.8.3 Global Whooping Cough Preventable Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Whooping Cough Preventable Vaccine Market Scenario by Region
3.1 Global Whooping Cough Preventable Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Whooping Cough Preventable Vaccine Sales by Region: 2019-2030
3.2.1 Global Whooping Cough Preventable Vaccine Sales by Region: 2019-2024
3.2.2 Global Whooping Cough Preventable Vaccine Sales by Region: 2025-2030
3.3 Global Whooping Cough Preventable Vaccine Revenue by Region: 2019-2030
3.3.1 Global Whooping Cough Preventable Vaccine Revenue by Region: 2019-2024
3.3.2 Global Whooping Cough Preventable Vaccine Revenue by Region: 2025-2030
3.4 North America Whooping Cough Preventable Vaccine Market Facts & Figures by Country
3.4.1 North America Whooping Cough Preventable Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Whooping Cough Preventable Vaccine Sales by Country (2019-2030)
3.4.3 North America Whooping Cough Preventable Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Whooping Cough Preventable Vaccine Market Facts & Figures by Country
3.5.1 Europe Whooping Cough Preventable Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Whooping Cough Preventable Vaccine Sales by Country (2019-2030)
3.5.3 Europe Whooping Cough Preventable Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Whooping Cough Preventable Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Whooping Cough Preventable Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Whooping Cough Preventable Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Whooping Cough Preventable Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Whooping Cough Preventable Vaccine Market Facts & Figures by Country
3.7.1 Latin America Whooping Cough Preventable Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Whooping Cough Preventable Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Whooping Cough Preventable Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Whooping Cough Preventable Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Whooping Cough Preventable Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Whooping Cough Preventable Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Whooping Cough Preventable Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Whooping Cough Preventable Vaccine Sales by Type (2019-2030)
4.1.1 Global Whooping Cough Preventable Vaccine Sales by Type (2019-2024)
4.1.2 Global Whooping Cough Preventable Vaccine Sales by Type (2025-2030)
4.1.3 Global Whooping Cough Preventable Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Whooping Cough Preventable Vaccine Revenue by Type (2019-2030)
4.2.1 Global Whooping Cough Preventable Vaccine Revenue by Type (2019-2024)
4.2.2 Global Whooping Cough Preventable Vaccine Revenue by Type (2025-2030)
4.2.3 Global Whooping Cough Preventable Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Whooping Cough Preventable Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Whooping Cough Preventable Vaccine Sales by Application (2019-2030)
5.1.1 Global Whooping Cough Preventable Vaccine Sales by Application (2019-2024)
5.1.2 Global Whooping Cough Preventable Vaccine Sales by Application (2025-2030)
5.1.3 Global Whooping Cough Preventable Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Whooping Cough Preventable Vaccine Revenue by Application (2019-2030)
5.2.1 Global Whooping Cough Preventable Vaccine Revenue by Application (2019-2024)
5.2.2 Global Whooping Cough Preventable Vaccine Revenue by Application (2025-2030)
5.2.3 Global Whooping Cough Preventable Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Whooping Cough Preventable Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Whooping Cough Preventable Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Whooping Cough Preventable Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Whooping Cough Preventable Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Whooping Cough Preventable Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Company Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Company Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics Whooping Cough Preventable Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics Whooping Cough Preventable Vaccine Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Company Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Whooping Cough Preventable Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Walvax Biotechnology Whooping Cough Preventable Vaccine Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.7.1 Chengdu Institute of Biological Products Company Information
6.7.2 Chengdu Institute of Biological Products Description and Business Overview
6.7.3 Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Company Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology Whooping Cough Preventable Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Minhai Biotechnology Whooping Cough Preventable Vaccine Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Whooping Cough Preventable Vaccine Industry Chain Analysis
7.2 Whooping Cough Preventable Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Whooping Cough Preventable Vaccine Production Mode & Process
7.4 Whooping Cough Preventable Vaccine Sales and Marketing
7.4.1 Whooping Cough Preventable Vaccine Sales Channels
7.4.2 Whooping Cough Preventable Vaccine Distributors
7.5 Whooping Cough Preventable Vaccine Customers
8 Whooping Cough Preventable Vaccine Market Dynamics
8.1 Whooping Cough Preventable Vaccine Industry Trends
8.2 Whooping Cough Preventable Vaccine Market Drivers
8.3 Whooping Cough Preventable Vaccine Market Challenges
8.4 Whooping Cough Preventable Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
List of Tables
 Table 1. Global Whooping Cough Preventable Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Whooping Cough Preventable Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Whooping Cough Preventable Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Whooping Cough Preventable Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Whooping Cough Preventable Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Whooping Cough Preventable Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Whooping Cough Preventable Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Whooping Cough Preventable Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Whooping Cough Preventable Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Whooping Cough Preventable Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Whooping Cough Preventable Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Whooping Cough Preventable Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whooping Cough Preventable Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Whooping Cough Preventable Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Whooping Cough Preventable Vaccine Sales by Region (2019-2024) & (K Dose)
 Table 18. Global Whooping Cough Preventable Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Whooping Cough Preventable Vaccine Sales by Region (2025-2030) & (K Dose)
 Table 20. Global Whooping Cough Preventable Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Whooping Cough Preventable Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Whooping Cough Preventable Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Whooping Cough Preventable Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Whooping Cough Preventable Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Whooping Cough Preventable Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Whooping Cough Preventable Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 27. North America Whooping Cough Preventable Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 28. North America Whooping Cough Preventable Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Whooping Cough Preventable Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Whooping Cough Preventable Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Whooping Cough Preventable Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 32. Europe Whooping Cough Preventable Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 33. Europe Whooping Cough Preventable Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Whooping Cough Preventable Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Whooping Cough Preventable Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Whooping Cough Preventable Vaccine Sales by Region (2019-2024) & (K Dose)
 Table 37. Asia Pacific Whooping Cough Preventable Vaccine Sales by Region (2025-2030) & (K Dose)
 Table 38. Asia Pacific Whooping Cough Preventable Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Whooping Cough Preventable Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Whooping Cough Preventable Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Whooping Cough Preventable Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 42. Latin America Whooping Cough Preventable Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 43. Latin America Whooping Cough Preventable Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Whooping Cough Preventable Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Whooping Cough Preventable Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Whooping Cough Preventable Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 47. Middle East and Africa Whooping Cough Preventable Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 48. Middle East and Africa Whooping Cough Preventable Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Whooping Cough Preventable Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Whooping Cough Preventable Vaccine Sales (K Dose) by Type (2019-2024)
 Table 51. Global Whooping Cough Preventable Vaccine Sales (K Dose) by Type (2025-2030)
 Table 52. Global Whooping Cough Preventable Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Whooping Cough Preventable Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Whooping Cough Preventable Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Whooping Cough Preventable Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Whooping Cough Preventable Vaccine Sales (K Dose) by Application (2019-2024)
 Table 61. Global Whooping Cough Preventable Vaccine Sales (K Dose) by Application (2025-2030)
 Table 62. Global Whooping Cough Preventable Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Whooping Cough Preventable Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Whooping Cough Preventable Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Whooping Cough Preventable Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Whooping Cough Preventable Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Application (2025-2030)
 Table 70. Sanofi Pasteur Company Information
 Table 71. Sanofi Pasteur Description and Business Overview
 Table 72. Sanofi Pasteur Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Sanofi Pasteur Whooping Cough Preventable Vaccine Product
 Table 74. Sanofi Pasteur Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. GSK Whooping Cough Preventable Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Mitsubishi Tanabe Pharma Company Information
 Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 82. Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Mitsubishi Tanabe Pharma Whooping Cough Preventable Vaccine Product
 Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 85. KM Biologics Company Information
 Table 86. KM Biologics Description and Business Overview
 Table 87. KM Biologics Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. KM Biologics Whooping Cough Preventable Vaccine Product
 Table 89. KM Biologics Recent Developments/Updates
 Table 90. Wuhan Institute of Biological Products Company Information
 Table 91. Wuhan Institute of Biological Products Description and Business Overview
 Table 92. Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Wuhan Institute of Biological Products Whooping Cough Preventable Vaccine Product
 Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
 Table 95. Walvax Biotechnology Company Information
 Table 96. Walvax Biotechnology Description and Business Overview
 Table 97. Walvax Biotechnology Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. Walvax Biotechnology Whooping Cough Preventable Vaccine Product
 Table 99. Walvax Biotechnology Recent Developments/Updates
 Table 100. Chengdu Institute of Biological Products Company Information
 Table 101. Chengdu Institute of Biological Products Description and Business Overview
 Table 102. Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 103. Chengdu Institute of Biological Products Whooping Cough Preventable Vaccine Product
 Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
 Table 105. Minhai Biotechnology Company Information
 Table 106. Minhai Biotechnology Description and Business Overview
 Table 107. Minhai Biotechnology Whooping Cough Preventable Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 108. Minhai Biotechnology Whooping Cough Preventable Vaccine Product
 Table 109. Minhai Biotechnology Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Whooping Cough Preventable Vaccine Distributors List
 Table 113. Whooping Cough Preventable Vaccine Customers List
 Table 114. Whooping Cough Preventable Vaccine Market Trends
 Table 115. Whooping Cough Preventable Vaccine Market Drivers
 Table 116. Whooping Cough Preventable Vaccine Market Challenges
 Table 117. Whooping Cough Preventable Vaccine Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Whooping Cough Preventable Vaccine
 Figure 2. Global Whooping Cough Preventable Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Whooping Cough Preventable Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Acellular Vaccines Product Picture
 Figure 5. Whole-Cell Vaccines Product Picture
 Figure 6. Global Whooping Cough Preventable Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Whooping Cough Preventable Vaccine Market Share by Application: 2023 & 2030
 Figure 8. 12 Months Below
 Figure 9. 12 Months Above
 Figure 10. Global Whooping Cough Preventable Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Whooping Cough Preventable Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Whooping Cough Preventable Vaccine Sales (2019-2030) & (K Dose)
 Figure 13. Global Whooping Cough Preventable Vaccine Average Price (US$/Dose) & (2019-2030)
 Figure 14. Whooping Cough Preventable Vaccine Report Years Considered
 Figure 15. Whooping Cough Preventable Vaccine Sales Share by Manufacturers in 2023
 Figure 16. Global Whooping Cough Preventable Vaccine Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Whooping Cough Preventable Vaccine Players: Market Share by Revenue in Whooping Cough Preventable Vaccine in 2023
 Figure 18. Whooping Cough Preventable Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Whooping Cough Preventable Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Whooping Cough Preventable Vaccine Sales Market Share by Country (2019-2030)
 Figure 21. North America Whooping Cough Preventable Vaccine Revenue Market Share by Country (2019-2030)
 Figure 22. United States Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Whooping Cough Preventable Vaccine Sales Market Share by Country (2019-2030)
 Figure 25. Europe Whooping Cough Preventable Vaccine Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Whooping Cough Preventable Vaccine Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Whooping Cough Preventable Vaccine Revenue Market Share by Region (2019-2030)
 Figure 33. China Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Whooping Cough Preventable Vaccine Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Whooping Cough Preventable Vaccine Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Whooping Cough Preventable Vaccine Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Whooping Cough Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Whooping Cough Preventable Vaccine by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Whooping Cough Preventable Vaccine by Type (2019-2030)
 Figure 52. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Whooping Cough Preventable Vaccine by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Whooping Cough Preventable Vaccine by Application (2019-2030)
 Figure 55. Global Whooping Cough Preventable Vaccine Price (US$/Dose) by Application (2019-2030)
 Figure 56. Whooping Cough Preventable Vaccine Value Chain
 Figure 57. Whooping Cough Preventable Vaccine Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Pertussis Vaccination Market Research Report 2025
Global Pertussis Vaccine Market Insights Forecast to 2030
Global Pertussis Booster Vaccine Market Research Report 2024
Global Pediatric Preventable Vaccine Market Research Report 2024
Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Research Report 2024
Global DTaP and Tdap Vaccines Market Insights Forecast to 2030
Global Pertussis Treatment Market Research Report 2024
Global Diphtheria Tetanus and Pertussis DTaP Vaccine Market Research Report 2024
Global Bordetella Pertussis ELISA Kits Market Research Report 2024
Global Whooping Cough Treatment Market Research Report 2025
Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025
Global Maternal Pertussis Vaccine for Newborn Protection Market Research Report 2024
Global Adult Preventable Vaccines Market Research Report 2024
Global Combined Polio Vaccine Market Research Report 2024
Global Poliomyelitis Vaccine Market Research Report 2025
Rabies Vaccine Market
Global Rabies Vaccination Market Research Report 2025
Global Rotavirus Vaccine Market Research Report 2024
Global Preventive Vaccines Market Insights Forecast to 2030
Global Pentavalent Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions